Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Krutika Amin"'
Autor:
Justin G Trogdon, Krutika Amin, Parul Gupta, Benjamin Y Urick, Katherine E Reeder-Hayes, Joel F Farley, Stephanie B Wheeler, Lisa Spees, Jennifer L Lund
Publikováno v:
PLoS ONE, Vol 16, Iss 11, p e0260358 (2021)
BackgroundWe conducted a mediation analysis of the provider team's role in changes to chronic condition medication adherence among cancer survivors.MethodsWe used a retrospective, longitudinal cohort design following Medicare beneficiaries from 18-mo
Externí odkaz:
https://doaj.org/article/bcafc9db25ae4b6680b74dfb633e9098
Autor:
James Wrocklage, Melvin J. Ingber, Kelly Drury, John Kautter, Gregory Pope, Andrew Pearlman, Krutika Amin
Publikováno v:
Medical Care. 58:504-510
BACKGROUND The 2010 Patient Protection and Affordable Care Act reformed the individual and small group health insurance markets and established a risk adjustment program to create a level playing field for competition. A new set of predictive models
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5116401ac56f49094ed06a66a6fa4370
https://doi.org/10.1097/mlr.0000000000001302
https://doi.org/10.1097/mlr.0000000000001302
Autor:
John Kautter, Brett Lissenden, Gregory Pope, Kelly Drury, Yolanda Peele, Krutika Amin, Erin Sutton
Publikováno v:
Medical Care. 58:146-153
Background The Patient Protection and Affordable Care Act (PPACA) established new parameters for the individual and small group health insurance markets starting in 2014. We study these 2 reformed markets by comparing health risk and costs to the mor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24821ca5c46a2e770c250c0ab1a1dd55
https://doi.org/10.1097/mlr.0000000000001239
https://doi.org/10.1097/mlr.0000000000001239
Publikováno v:
Journal of managed carespecialty pharmacy. 23(3)
In 2001, the North Carolina (NC) Medicaid program reduced the number of days prescription supply that enrollees could fill from 100 days to 34 days and increased copayments for brand-name medications. Previous work has shown that a change in these po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::714f3649d622d1bc1fa1535c333e41ca
https://pubmed.ncbi.nlm.nih.gov/28230447
https://pubmed.ncbi.nlm.nih.gov/28230447
Autor:
C. Edward Dixon, Robert S. B. Clark, Anthony Fabio, Krutika Amin, Haishin Ozawa, Patrick M. Kochanek, Emily H. McCullough, Christian Niyonkuru, Brett A. Postal, Hülya Bayır, Amy K. Wagner
Publikováno v:
Journal of Cerebral Blood Flow & Metabolism. 31:1886-1896
The biochemical cascades associated with cell death after traumatic brain injury (TBI) involve both pro-survival and pro-apoptotic proteins. We hypothesized that elevated cerebrospinal fluid (CSF) Bcl-2 and cytochrome C (CytoC) levels over time would
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e8047e2f9d9d081f92b33efabc7a752
https://doi.org/10.1038/jcbfm.2011.31
https://doi.org/10.1038/jcbfm.2011.31
Publikováno v:
Journal of neurotrauma. 30(11)
Over the last decade, biomarker research has identified potential biomarkers for the diagnosis, prognosis, and management of traumatic brain injury (TBI). Several cerebrospinal fluid (CSF) and serum biomarkers have shown promise in predicting long-te
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::672c85f3ee66bf3ab60f240710a063e7
https://pubmed.ncbi.nlm.nih.gov/23421760
https://pubmed.ncbi.nlm.nih.gov/23421760